Next Article in Journal
18:0 Lyso PC Derived by Bioactivity-Based Molecular Networking from Lentil Mutant Lines and Its Effects on High-Fat Diet-Induced Obese Mice
Next Article in Special Issue
The Role of Microencapsulation in Food Application
Previous Article in Journal
Insights on the Inhibitory Power of Flavonoids on Tyrosinase Activity: A Survey from 2016 to 2021
Previous Article in Special Issue
Pulsed Power Applications for Protein Conformational Change and the Permeabilization of Agricultural Products
 
 
Article
Peer-Review Record

Composition, Anti-MRSA Activity and Toxicity of Essential Oils from Cymbopogon Species

Molecules 2021, 26(24), 7542; https://doi.org/10.3390/molecules26247542
by Bartłomiej Piasecki 1,*, Anna Biernasiuk 2, Adrianna Skiba 3, Krystyna Skalicka-Woźniak 3 and Agnieszka Ludwiczuk 1
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Reviewer 3: Anonymous
Molecules 2021, 26(24), 7542; https://doi.org/10.3390/molecules26247542
Submission received: 15 November 2021 / Revised: 5 December 2021 / Accepted: 8 December 2021 / Published: 13 December 2021
(This article belongs to the Special Issue Extraction, Processing, and Encapsulation of Food Bioactive Compounds)

Round 1

Reviewer 1 Report

This paper analyzed the chemical composition of 19 essential oils from Cymbopogon species, and antimicrobial activity and toxicity of selected essential oils were evaluated.  The experimental design needs to be clarified, the statistical analysis section is missing, and the language could be improved.

The following points need to be addressed:

  • The language and format of the manuscript need to be improved, for example: Line 27 change ‘significant problem’ to ‘ a significant problem’;  Lines 43, 96, 255, change ‘;’ to ‘:’;  Line 95, change ‘grup’ to ‘group’;  Table 4, change 'C flexuosus' to 'C. flexuosus', and 'C martinii (Palmarosa)' to 'C. martinii (Palmarosa)'.
  • Line 104, change ’11.4’ to ’11.5.’
  • For Table 1: what the numbers represent for should be explained in the title.
  • How did you calculate the percentage in Table 1? Did you run the standard for each compound to get the concentration?
  • For the antimicrobial activity and toxicity assay, is there any reason to choose different representative compound for each chemotype? Why did you use both number 8 and 10 as control for the toxicity assay?
  • Table 3, the chemotype should be in order from I to V.
  • Line 139, change ‘Table 1’ to ‘Table 4’.
  • Tables 2 and 3 also need to mention: For EOs numbering see Table 4.
  • In the method section for the toxicity assay, the numbers of selected EOs should be mentioned.
  • The statistical analysis information should be provided. Is there any significant differences for the values listed in each table (Tables 1, 2 and 3)?

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Reviewer 2 Report

The paper by Piasecki B. et al., entitled "Composition, anti-MRSA activity and toxicity of essential oils from Cymbopogon species" investigated the chemical analysis of 19 essential oils (EOs) from seven different Cymbopogon species, their antimicrobial and antibiofilm activity against MRSA and the toxicity of EOs. The authors revealed a interesting potential antistaphylococcal effect from Cymbopogon species. The manuscript is well-written. The study has been done carefully and the methods are appropriate. The paper is immediately acceptable for publication in the journal, but it is necessary to check the references for example number 34 is not correct

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Reviewer 3 Report

The manuscript was well written and scientific solid. The work is not very novel, however, it shown some new results from Cymbopogon essential oils that worth the publication. Please insert material and method section before the results. The first part of the discussion is mostly not discussing the results and can be deleted or added to the introduction.

Author Response

I would like this part to be left where it is now.

 

Back to TopTop